Lung Cancers Completed Phase 2 Trials for Amifostine (DB01143)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00078845Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid TumorsSupportive Care
NCT00004176Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerTreatment
NCT00003089Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung CancerTreatment
NCT00003072Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung CancerSupportive Care
NCT00003269Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid TumorsSupportive Care
NCT00003657High-dose ICE With AmifostineTreatment